Mitotech
PrivateLast Round
Strategic
Jul 16, 2018
Total Funding Raised
$17M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Mitotech operates in Healthcare & Life Sciences and is based in Luxembourg. Its latest recorded funding round was a Strategic round in July 2018.
Mitotech is a biotechnology company that develops novel drugs for the treatment of age-related disorders based on mitochondria-targeting cardiolipin peroxidation inhibitors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitotech Comparables
Compare Mitotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaliq | 81% | |
| Stuart Therapeutics, Inc. | 79% | |
| Aldeyra Therapeutics | 78% |
For institutional investors. Book with your work email.
Mitotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 16, 2018 | ||||
| VC Round | Feb 24, 2010 |
For institutional investors. Book with your work email.
Mitotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Essex Bio-Technology | Strategic |
| Rusnano | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2026
Presenting new data on treatment candidate MT-1101 at ObesityWeek(R) 2026.
- Nov 12, 2026
New data on obesity treatment candidate MT-1101 to be presented at ObesityWeek 2026.
For institutional investors. Book with your work email.
Mitotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mitotech's valuation, stock price, and market status.
Is Mitotech a public or private company?
Mitotech is a private company.
What is the current stock price of Mitotech?
Mitotech is a private company, so its shares have no public market price. Caplight tracks Mitotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mitotech worth (valuation)?
Valuation information for Mitotech is not publicly available.
Can I buy Mitotech stock?
Mitotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mitotech's last funding round?
Mitotech's most recent funding round was Strategic on July 16, 2018.
Who are the main investors in Mitotech?
Key investors in Mitotech include Essex Bio-Technology, Rusnano.
Will Mitotech IPO soon?
No public IPO plans have been announced for Mitotech.
How can I track Mitotech secondary market activity?
Caplight tracks bids, offers, and trades in Mitotech's shares on secondary markets.